The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

Abroad (travel likely)RecruitingPHASE3

Conditions

AML (Acute Myelogenous Leukemia) · Down Syndrome (DS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow, Russia

    Contact: Study coordinator (Lena f Smirnova) · lena.smirnova@dgoi.ru · +7(985)130-61-03